Method for extracting microvesicles from biological sample

Patent metadata

Field	Value
Publication number	US-12551828-B2
Application number	US-202017430429-A
Country	US
Kind code	B2
Filing date	Feb 12, 2020
Priority date	Feb 14, 2019
Publication date	Feb 17, 2026
Grant date	Feb 17, 2026

Abstract

The present invention relates to a method for extracting microvesicles from a biological sample, the method comprising the steps of: adding a polyvalent cationic material to the biological sample to form an aggregate in which the microvesicles and the polyvalent cationic material are aggregated by electrical force; capturing the aggregate by a capture filter while the biological sample including the aggregate passes through the capture filter; and extracting the microvesicles by allowing an elution solution to pass through the capture filter with the aggregate captured therein to isolate the microvesicles from the aggregate. Accordingly, microvesicles may be extracted using a polyvalent cationic material, without a centrifugation process.

First claim

What is claimed is:

1 . A method for extracting microvesicles from a biological sample, the method comprising:
adding a polyvalent cationic substance to the biological sample to form multiple aggregates in which the microvesicles and the polyvalent cationic substance are aggregated with other via an electrical force; passing the biological sample containing the aggregates through a capture filter while the aggregates are captured by the capture filter; passing an elution solution through the capture filter where the aggregates are captured such that the microvesicles are separated from the aggregates, and then extracting the separated microvesicles, wherein the polyvalent cationic substance comprises polyarginine, polyhistidine, cationic dendrimer, polyamidoamine, polyquaternium, or a combination thereof.

2 . A method for extracting microvesicles from a biological sample, the method comprising: adding a polyvalent cationic substance to the biological sample to form multiple aggregates in which the microvesicles and the polyvalent cationic substance are aggregated with other via an electrical force; passing the biological sample containing the aggregates through a capture filter while the aggregates are captured by the capture filter; passing a buffer solution having a negative charge through the capture filter in which the aggregates are captured such that the aggregates are released from the capture filter; and injecting an elution solution into the aggregates released from the capture filter such that the microvesicles are separated from the aggregates, and then extracting the separated microvesicles, wherein the capture filter comprises a hydrophilic material selected from the group consisting of sliver metal, polyethersulfone, glass fiber, polycarbonate track etch (PCTE), and mixed cellulose esters, and wherein the polyvalent cationic substance comprises polyarginine, poly histidine, cationic dendrimer, poly amidoamine, polyquaternium, or a combination thereof.

3 . The method of claim 1 , wherein the elution solution contains a chaotropic agent or protease.

4 . The method of claim 1 , wherein the biological sample comprises blood, plasma, serum, urine, saliva, cerebrospinal fluid, tear, sweat, feces, ascites, amniotic fluid, semen, milk, cell medium, tissue extract or cancer tissue.

5 . The method of claim 3 , wherein the chaotropic agent comprises a salt comprising guanidinium ion, n-butanol, ethanol, lithium perchlorate, lithium acetate, magnesium chloride, phenol, 2-propanol, sodium dodecyl sulfate, thiourea, urea, or a combination thereof.

6 . The method of claim 3 , wherein the protease comprises proteinase K, pepsin, trypsin or chymotrypsin.

7 . The method of claim 1 , wherein the capture filter has pores of a size capable of capturing the aggregates.

8 . The method of claim 7 , wherein the capture filter comprises at least one of:
a membrane having pores defined therein; or a bead packing filter in which a plurality of micro-beads are closely packed in a 3 dimensional manner so that pores are formed therein.

9 . The method of claim 7 , wherein the capture filter is made of a hydrophilic material or a cation exchange resin.

10 . The method of claim 2 , wherein the buffer solution contains at least one of Ca 2+ , Mg 2+ , Na + , K + , NH 4+ ions, or a combination thereof.

11 . The method of claim 2 , wherein the elution solution comprises a chaotropic agent or protease.

12 . The method of claim 2 , wherein the biological sample comprises blood, plasma, serum, urine, saliva, cerebrospinal fluid, tear, sweat, feces, ascites, amniotic fluid, semen, milk, cell medium, tissue extract or cancer tissue.

13 . The method of claim 11 , wherein the chaotropic agent comprises a salt comprising guanidinium ion, n-butanol, ethanol, lithium perchlorate, lithium acetate, magnesium chloride, phenol, 2-propanol, sodium dodecyl sulfate, thiourea, urea, or a combination thereof.

14 . The method of claim 11 , wherein the protease comprises proteinase K, pepsin, trypsin or chymotrypsin.

15 . The method of claim 2 , wherein the capture filter has pores of a size capable of capturing the aggregates.

16 . The method of claim 15 , wherein the capture filter comprises at least one of:
a membrane having pores defined therein; or a bead packing filter in which a plurality of micro-beads are closely packed in a 3 dimensional manner so that pores are formed therein.

Assignees

• Univ Korea Res & Bus Found

Inventors

• Shin Se-Hyun
• Lee Ho-Yoon
• Na Won-Hwi
• Kim Jin-Hyun

Classifications

• B01D2311/2642

  Aggregation, sedimentation, flocculation, precipitation or coagulation · CPC title

• B01D2311/12

  Addition of chemical agents · CPC title

• B01D2311/04

  Specific process operations in the feed stream; Feed pretreatment · CPC title

• B01D61/16

  Feed pretreatment · CPC title

• B01D15/362

  Cation-exchange · CPC title